This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tianjin University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Lizhi Mi
Introduction
Lizhi Mi is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of biotechnology, particularly in the development of theranostic probes. His work focuses on targeting and labeling specific kinases and cells, which has important implications for cancer research and treatment.
Latest Patents
Lizhi Mi holds a patent for "A Theranostic Probe and its Use for Targeting and/or Labeling the EGFR Kinase and/or the Cells Expressing EGFR or its Family Members." This innovative probe is designed to enhance the precision of cancer therapies by specifically targeting the epidermal growth factor receptor (EGFR) and its related family members. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Currently, Lizhi Mi is affiliated with Tianjin University, where he continues to advance his research in biotechnology. His academic background and ongoing projects contribute to the university's reputation as a leading institution in scientific research.
Collaborations
Throughout his career, Lizhi Mi has collaborated with notable colleagues, including Zhiqun Shang and Peng Liu. These partnerships have fostered a collaborative environment that enhances innovation and research output.
Conclusion
Lizhi Mi's work in developing theranostic probes represents a significant advancement in targeted cancer therapies. His contributions to biotechnology continue to influence the field and inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile